Brodsky, I <br/><br/>
Treatment of chronic myelogenous leukemia with allogeneic bone marrow transplantation after preparation with busulfan and cyclophosphamide (BuCy2): an update.  [electronic resource] 

 -  Seminars in oncology  Aug 1993 
 - 27-31; quiz 32 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0093-7754 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Agents--therapeutic use<br/>Bone Marrow Transplantation--adverse effects<br/>Busulfan--administration & dosage<br/>Child<br/>Combined Modality Therapy<br/>Cyclophosphamide--administration & dosage<br/>Female<br/>Humans<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--mortality<br/>Male<br/>Middle Aged<br/>Morbidity<br/>Premedication<br/>Transplantation, Homologous<br/>Treatment Outcome